Professor Cho Ki-young of Hallim University's Gangnam Sacred Heart Hospital won the Seokcheon Academic Award of the Korean Pediatric Youth Association
Nov 17, 2025
Professor Cho Ki-young of the Department of Pediatrics and Adolescents at the Gangnam Sacred Heart Hospital (Hospital Director Lee Dong-jin) of Hanlim University won the Seokcheon Academic Award at the 75th Fall Conference of the Korean Academy of Pediatrics.
The Seokcheon Academic Award is the most prestigious academic award in the Korean Academy of Pediatrics and was established to honor the late Professor Hong Chang-eui (Ho Seok-cheon), the author of the textbook 'Pediatric Science' and who made a great contribution to the development of Korean pediatric and adolescent medicine.
This award is the result of recognizing the creativity and scientific excellence of research on predicting the reactivity of tumor necrosis factor inhibitors using intestinal organoids derived from pediatric adolescent inflammatory bowel disease patients.
Professor Cho Ki-young is conducting a study to predict the responsiveness of TNF-α inhibitor treatment in individual patients with inflammatory bowel disease in children and adolescents using Intestinal Organoid technology.
The intestinal organoid is a 'mini-organ' model that implements human intestinal (腸) structures and functions in three dimensions in vitro. It is manufactured by separating and culturing stem cells from patient endoscopic tissue, and maintains biological characteristics similar to the actual patient's intestinal condition. Using this, it is evaluated as a core technology of precision medicine as it can predict the treatment response before drug administration and design the optimal treatment strategy.
This study was started with the support of 'Lee Kun-hee's Childhood Cancer and Rare Diseases Overcoming Project' and"Halim University Medical Center Mighty Hallym4.0 Research Fund" and was selected as a project for advanced research (creative research) by the Korea Research Foundation in September, and the research will be expanded in earnest.
Professor Cho Ki-young said, "Study on predicting treatment responsiveness using intestinal organoids is an important attempt to lay the foundation for 'precise customized medical care' essential for patients with inflammatory bowel disease in children and adolescents. We will continue to apply research and clinical practice to present safer and more effective treatments to individual patients in the future."."
Professor Cho Ki-young is the director of the Department of Pediatrics and Adolescents at Hanlim University's Gangnam Sacred Heart Hospital and specializes in the fields of Gastroenterology, Hepatology, and Nutrition. Currently, he is actively conducting academic research and educational activities as the academic chairman of the Korean Society for Pediatric Gastrointestinal Nutrition, and focuses on diagnosing and treating digestive diseases such as childhood inflammatory bowel disease, liver dysfunction, and gastrointestinal disease.
The Seokcheon Academic Award is the most prestigious academic award in the Korean Academy of Pediatrics and was established to honor the late Professor Hong Chang-eui (Ho Seok-cheon), the author of the textbook 'Pediatric Science' and who made a great contribution to the development of Korean pediatric and adolescent medicine.
This award is the result of recognizing the creativity and scientific excellence of research on predicting the reactivity of tumor necrosis factor inhibitors using intestinal organoids derived from pediatric adolescent inflammatory bowel disease patients.
Professor Cho Ki-young is conducting a study to predict the responsiveness of TNF-α inhibitor treatment in individual patients with inflammatory bowel disease in children and adolescents using Intestinal Organoid technology.
The intestinal organoid is a 'mini-organ' model that implements human intestinal (腸) structures and functions in three dimensions in vitro. It is manufactured by separating and culturing stem cells from patient endoscopic tissue, and maintains biological characteristics similar to the actual patient's intestinal condition. Using this, it is evaluated as a core technology of precision medicine as it can predict the treatment response before drug administration and design the optimal treatment strategy.
This study was started with the support of 'Lee Kun-hee's Childhood Cancer and Rare Diseases Overcoming Project' and"Halim University Medical Center Mighty Hallym4.0 Research Fund" and was selected as a project for advanced research (creative research) by the Korea Research Foundation in September, and the research will be expanded in earnest.
Professor Cho Ki-young said, "Study on predicting treatment responsiveness using intestinal organoids is an important attempt to lay the foundation for 'precise customized medical care' essential for patients with inflammatory bowel disease in children and adolescents. We will continue to apply research and clinical practice to present safer and more effective treatments to individual patients in the future."."
Professor Cho Ki-young is the director of the Department of Pediatrics and Adolescents at Hanlim University's Gangnam Sacred Heart Hospital and specializes in the fields of Gastroenterology, Hepatology, and Nutrition. Currently, he is actively conducting academic research and educational activities as the academic chairman of the Korean Society for Pediatric Gastrointestinal Nutrition, and focuses on diagnosing and treating digestive diseases such as childhood inflammatory bowel disease, liver dysfunction, and gastrointestinal disease.
|
This article was translated by Naver AI translator.
